Revenue
2010
2011
2021
2022
2023
2024
2025
Actinium Pharmaceuticals, Inc. (ATNM)
Price—Loading quote
Net income
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $90,000 | $0 | $81,000 | $1.0M | $1.1M | — | — | — | — | — | — | — | — | — | $0 | $0 | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | $244,000 | — | — | — | — | — | — | — | — | — | $0 | $0 | — | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | 21.33% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research & development | $21.1M | $30.0M | $38.7M | $23.1M | $18.0M | $16.1M | $16.6M | $17.1M | $17.7M | $17.8M | $13.5M | $12.3M | $3.1M | $3.4M | $323,788 | — | — | — | — | — | — | — | — | — | — |
| Operating expenses | $36.3M | $42.1M | $52.0M | $35.1M | $26.1M | $22.4M | $22.1M | $23.8M | $26.9M | $26.8M | $24.8M | $22.5M | $6.6M | $7.9M | $3.3M | $26,053 | — | — | — | — | — | — | — | — | — |
| Operating income | −$36.2M | −$42.1M | −$51.9M | −$34.1M | −$25.0M | −$22.4M | −$22.1M | −$23.8M | −$26.9M | −$26.8M | −$24.8M | −$22.5M | −$6.6M | −$7.9M | −$3.3M | −$26,053 | — | — | — | — | — | — | — | — | — |
| Operating margin | −40,274.44% | — | −64,098.77% | −3,311.07% | −2,182.17% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −$36.1M | −$41.9M | −$51.7M | −$33.4M | −$24.4M | −$21.9M | −$21.7M | −$23.8M | −$26.9M | −$26.8M | −$24.8M | −$22.4M | −$6.6M | −$7.9M | −$3.3M | — | — | — | — | — | — | — | — | — | — |
| EBITDA margin | −40,082.22% | — | −63,843.21% | −3,243.20% | −2,136.36% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | −$33.9M | −$38.2M | −$48.8M | −$33.0M | −$24.8M | −$22.2M | −$21.9M | −$23.7M | −$26.6M | −$24.3M | −$21.0M | −$24.7M | −$10.8M | −$8.4M | −$3.4M | −$467,266 | −$3.4M | −$5.6M | −$5.6M | −$6.1M | −$4.6M | −$5.7M | −$3.5M | −$3.2M | −$5.1M |
| Net profit margin | −37,652.22% | — | −60,269.14% | −3,205.53% | −2,165.56% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic EPSper basic share | -$1.09 | -$1.27 | -$1.83 | -$1.37 | -$1.20 | -$1.83 | -$4.40 | -$6.60 | -$12.00 | -$15.00 | -$16.50 | -$27.00 | -$14.10 | -$227.40 | -$129.00 | $0.30 | — | — | — | — | — | — | — | — | — |
| Diluted EPSper diluted share | -$1.09 | -$1.27 | -$1.83 | -$1.37 | -$1.20 | -$1.83 | -$4.40 | -$6.60 | -$12.00 | -$15.00 | -$16.50 | -$27.00 | -$14.10 | -$227.40 | -$129.00 | $0.30 | — | — | — | — | — | — | — | — | — |
Owners
Reported shareholders
3.94%of listed shares
VANGUARD CAPITAL MANAGEMENT LLC1.24M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
VANGUARD CAPITAL MANAGEMENT LLC | 3.94%1.24M shares |
COMPASS FINANCIAL MANAGEMENT LLC | 1.91%600.23K shares |
MILLENNIUM MANAGEMENT LLC | 1.64%514.58K shares |
ACADIAN ASSET MANAGEMENT LLC | 1.58%496.29K shares |
BlackRock, Inc. | 1.26%395.9K shares |
RENAISSANCE TECHNOLOGIES LLC | 1.21%380.49K shares |
GEODE CAPITAL MANAGEMENT, LLC | 1.03%324.95K shares |
TWO SIGMA INVESTMENTS, LP | 0.82%259.18K shares |
SETH SANDESH | ≈0.59%184.48K shares |
GAGNON SECURITIES LLC | 0.58%182.14K shares |
VANGUARD FIDUCIARY TRUST CO | 0.51%161.53K shares |
STATE STREET CORP | 0.39%122.22K shares |
Gen-Wealth Partners Inc | 0.33%105.11K shares |
NORTHERN TRUST CORP | 0.22%69.74K shares |
Qube Research & Technologies Ltd | 0.18%57.81K shares |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.18%56.82K shares |
Vontobel Holding Ltd. | 0.16%50K shares |
Bluespring Wealth Management, LLC | 0.14%43K shares |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.13%40K shares |
AM INVESTMENT STRATEGIES LLC | 0.09%29.36K shares |
Percentages use 31.44M shares of this listed class outstanding on Jun 30, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data